|
H6 - health effect clinical code 4581: pigment dispersion.H6 - work order search: no similar complaint type events were reported for units within the same lot.Claim# (b)(4).Manufacturer narrative - manufacturer narrative - iritis and pigment dispersion are identified in the labeling as known potential adverse events following icl implantation.The dfu states for complications and adverse reactions: adverse reactions and complications due to, or following surgery and implantation of any evo/evo+ ticl may include, but are not limited to: hyphema, non-reactive pupil, pupillary block, additional yag iridotomy, secondary glaucoma, cataract, intraocular infection, uveitis/iritis, retinal detachment, vitritis, corneal edema, macular edema, corneal decompensation, over/under correction, significant glare and/or halos (under night driving conditions), hypopyon, increased astigmatism, loss of bscva, rotation/decentration/ subluxation, iop elevation from baseline, corneal endothelial cell loss, iris pigment dispersion, secondary surgical intervention to remove/replace/ reposition the lens, peripheral anterior synechia (pas), iris synechia to implant, conjunctival irritation, vitreous loss a precaution provided: (7) safety and effectiveness of the lens has not been established in patients with: unstable refractive error in either eye, keratoconus, history of clinical signs of iritis/uveitis, synechia, pigment dispersion syndrome, pseudoexfoliation, insulin-dependent diabetes or diabetic retinopathy, history of previous ocular surgery including refractive corneal surgery.In cases of episodic or recurrent inflammation, patient anatomy, systemic health and autoimmune factors are potential contributors.An exact cause could not be determined as the event could be multifactorial in nature including patient and procedural factors.
|